Explainer: how the US drug pricing law affects Medicare and its members

Reuters

13 September 2022 - U.S. President Joe Biden last month signed the $430 billion Inflation Reduction Act, authorising the federal government to negotiate prices on some prescription drugs and cap costs for the government's Medicare health program.

Here is how the law may affect some of the 63 million Americans aged 65 or over or with disabilities who receive Medicare health benefits.

Read Reuters article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Medicare , Pricing